

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.07330196 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 7.92104992 |
| 3 | regulation of B cell receptor signaling pathway (GO:0050855) | 7.11304564 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.03011376 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.24643558 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.24643558 |
| 7 | positive thymic T cell selection (GO:0045059) | 6.16555590 |
| 8 | cellular response to interleukin-15 (GO:0071350) | 5.71547532 |
| 9 | response to interleukin-15 (GO:0070672) | 5.62202410 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.55155616 |
| 11 | regulation of B cell differentiation (GO:0045577) | 5.41648104 |
| 12 | cellular response to zinc ion (GO:0071294) | 5.39313166 |
| 13 | mature B cell differentiation (GO:0002335) | 5.26741434 |
| 14 | negative thymic T cell selection (GO:0045060) | 5.24517479 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 5.10420794 |
| 16 | negative T cell selection (GO:0043383) | 5.07312775 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.00262783 |
| 18 | B cell proliferation (GO:0042100) | 4.97731709 |
| 19 | thymic T cell selection (GO:0045061) | 4.92241404 |
| 20 | positive T cell selection (GO:0043368) | 4.85758992 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.82064341 |
| 22 | negative regulation of cell killing (GO:0031342) | 4.82064341 |
| 23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.60280811 |
| 24 | T cell selection (GO:0045058) | 4.58687261 |
| 25 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.55199838 |
| 26 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.53446588 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.45267072 |
| 28 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.33089160 |
| 29 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.28126355 |
| 30 | tolerance induction (GO:0002507) | 4.27472481 |
| 31 | regulation of B cell proliferation (GO:0030888) | 4.26563410 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 4.23327466 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14999404 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.13014292 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 4.12260487 |
| 36 | detection of bacterium (GO:0016045) | 4.11426761 |
| 37 | mature B cell differentiation involved in immune response (GO:0002313) | 4.04600040 |
| 38 | neutrophil activation involved in immune response (GO:0002283) | 3.99015179 |
| 39 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.95917243 |
| 40 | detection of other organism (GO:0098543) | 3.95189552 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.90286019 |
| 42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.88271975 |
| 43 | positive regulation of B cell proliferation (GO:0030890) | 3.87516945 |
| 44 | positive regulation of interleukin-2 production (GO:0032743) | 3.84399601 |
| 45 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.79124727 |
| 46 | T cell costimulation (GO:0031295) | 3.78889697 |
| 47 | negative regulation of B cell proliferation (GO:0030889) | 3.78073206 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.77899525 |
| 49 | defense response to protozoan (GO:0042832) | 3.74699322 |
| 50 | B cell homeostasis (GO:0001782) | 3.71902414 |
| 51 | lymphocyte costimulation (GO:0031294) | 3.71827671 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.66471761 |
| 53 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.66176764 |
| 54 | type I interferon signaling pathway (GO:0060337) | 3.65305071 |
| 55 | cellular response to type I interferon (GO:0071357) | 3.65305071 |
| 56 | response to type I interferon (GO:0034340) | 3.63149287 |
| 57 | leukocyte aggregation (GO:0070486) | 3.61789946 |
| 58 | T cell migration (GO:0072678) | 3.60903886 |
| 59 | lymphocyte homeostasis (GO:0002260) | 3.57620194 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 3.56413372 |
| 61 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.55533562 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.55533562 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 3.54447639 |
| 64 | negative regulation of bone resorption (GO:0045779) | 3.53752810 |
| 65 | germinal center formation (GO:0002467) | 3.52425589 |
| 66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.48777366 |
| 67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.48587837 |
| 68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.48587837 |
| 69 | modulation by symbiont of host immune response (GO:0052553) | 3.48587837 |
| 70 | positive regulation by symbiont of host defense response (GO:0052509) | 3.48587837 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 3.48587837 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.48587837 |
| 73 | viral transcription (GO:0019083) | 3.48550888 |
| 74 | positive regulation of B cell activation (GO:0050871) | 3.46656536 |
| 75 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.45133186 |
| 76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43456249 |
| 77 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.43043391 |
| 78 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.41563086 |
| 79 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.40686933 |
| 80 | cytidine metabolic process (GO:0046087) | 3.40655419 |
| 81 | cytidine catabolic process (GO:0006216) | 3.40655419 |
| 82 | cytidine deamination (GO:0009972) | 3.40655419 |
| 83 | regulation of B cell apoptotic process (GO:0002902) | 3.40566362 |
| 84 | negative regulation of interleukin-12 production (GO:0032695) | 3.40370606 |
| 85 | regulation of B cell activation (GO:0050864) | 3.39806387 |
| 86 | T cell homeostasis (GO:0043029) | 3.39428346 |
| 87 | positive regulation of immunoglobulin production (GO:0002639) | 3.37896734 |
| 88 | * B cell activation (GO:0042113) | 3.37039391 |
| 89 | T cell receptor signaling pathway (GO:0050852) | 3.36441177 |
| 90 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.34297140 |
| 91 | response to protozoan (GO:0001562) | 3.30855864 |
| 92 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.30640133 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.30570664 |
| 94 | negative regulation of B cell apoptotic process (GO:0002903) | 3.29793752 |
| 95 | immunoglobulin mediated immune response (GO:0016064) | 3.27459536 |
| 96 | neutrophil activation (GO:0042119) | 3.26231837 |
| 97 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.25791785 |
| 98 | negative regulation of phagocytosis (GO:0050765) | 3.25667996 |
| 99 | translational termination (GO:0006415) | 3.23771514 |
| 100 | lymphocyte proliferation (GO:0046651) | 3.22871698 |
| 101 | mononuclear cell proliferation (GO:0032943) | 3.20590991 |
| 102 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.18561155 |
| 103 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.18241036 |
| 104 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.18241036 |
| 105 | myeloid cell activation involved in immune response (GO:0002275) | 3.18207464 |
| 106 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.17109938 |
| 107 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15742513 |
| 108 | ribosomal small subunit assembly (GO:0000028) | 3.14808792 |
| 109 | B cell mediated immunity (GO:0019724) | 3.14167676 |
| 110 | regulation of tolerance induction (GO:0002643) | 3.13371704 |
| 111 | granulocyte activation (GO:0036230) | 3.12774224 |
| 112 | positive regulation of interferon-alpha production (GO:0032727) | 3.11933009 |
| 113 | respiratory burst (GO:0045730) | 3.11218095 |
| 114 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.10777340 |
| 115 | mast cell activation (GO:0045576) | 3.09806435 |
| 116 | positive regulation of type 2 immune response (GO:0002830) | 3.09624964 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 3.09041859 |
| 118 | leukocyte homeostasis (GO:0001776) | 3.07880605 |
| 119 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.07493111 |
| 120 | leukocyte degranulation (GO:0043299) | 3.06756650 |
| 121 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.04964792 |
| 122 | positive regulation of Rap GTPase activity (GO:0032854) | 3.04550360 |
| 123 | regulation of alpha-beta T cell activation (GO:0046634) | 3.03293409 |
| 124 | activated T cell proliferation (GO:0050798) | 3.02999561 |
| 125 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.00593067 |
| 126 | regulation of interferon-alpha production (GO:0032647) | 2.99323466 |
| 127 | positive regulation of granulocyte differentiation (GO:0030854) | 2.97863047 |
| 128 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.97261870 |
| 129 | leukocyte proliferation (GO:0070661) | 2.96387119 |
| 130 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.93193728 |
| 131 | ribosomal small subunit biogenesis (GO:0042274) | 2.92780173 |
| 132 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.92666527 |
| 133 | myeloid dendritic cell activation (GO:0001773) | 2.92277034 |
| 134 | B cell activation involved in immune response (GO:0002312) | 2.91516055 |
| 135 | B cell differentiation (GO:0030183) | 2.89651664 |
| 136 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.89178184 |
| 137 | positive regulation of isotype switching (GO:0045830) | 2.86422352 |
| 138 | positive regulation of histone deacetylation (GO:0031065) | 2.83807262 |
| 139 | immune response-activating signal transduction (GO:0002757) | 2.82458346 |
| 140 | interferon-gamma production (GO:0032609) | 2.82348474 |
| 141 | positive regulation of interleukin-12 production (GO:0032735) | 2.81831565 |
| 142 | negative regulation of bone remodeling (GO:0046851) | 2.81346898 |
| 143 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.80211142 |
| 144 | regulation of immunoglobulin production (GO:0002637) | 2.79691162 |
| 145 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.76629172 |
| 146 | regulation of regulatory T cell differentiation (GO:0045589) | 2.75261578 |
| 147 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.74255443 |
| 148 | T cell proliferation (GO:0042098) | 2.74178268 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.69839711 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.41982811 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.91873001 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 4.76433302 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.61416923 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.10333073 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.55391120 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.20468099 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18169962 |
| 10 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.16838121 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.14440434 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.86177354 |
| 13 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.80913221 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.80406837 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79832745 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.79298912 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73441002 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.70074295 |
| 19 | * MYB_26560356_Chip-Seq_TH1_Human | 2.66970361 |
| 20 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.63530302 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.61683679 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52627489 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.46568511 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45966106 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.40143554 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27345468 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.19656872 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17806584 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.08746120 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08249838 |
| 31 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.06817173 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.05413080 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.03177010 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99347470 |
| 35 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.95782168 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.93290251 |
| 37 | * MAF_26560356_Chip-Seq_TH2_Human | 1.92316508 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81200708 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79840345 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77426329 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.76723923 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66876153 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63442394 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62888624 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60947911 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56151309 |
| 47 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53234910 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52814855 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50628702 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44770424 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44015120 |
| 52 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42000472 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32585421 |
| 54 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31880806 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31183902 |
| 56 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28738155 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27710195 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.27472979 |
| 59 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23955417 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23517598 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21989954 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19707454 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19326258 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16633541 |
| 65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15445166 |
| 66 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13787550 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12787958 |
| 68 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11925061 |
| 69 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10245017 |
| 70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09496001 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09472390 |
| 72 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09232512 |
| 73 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07405556 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06286236 |
| 75 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03786318 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02561049 |
| 77 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.02018157 |
| 78 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99486819 |
| 79 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99242863 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98022591 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97995068 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96814376 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94510067 |
| 84 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94452923 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92355055 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90372524 |
| 87 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.89742784 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.88286340 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86400626 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.85478959 |
| 91 | P68_20966046_ChIP-Seq_HELA_Human | 0.84775988 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84603750 |
| 93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.83878403 |
| 94 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82270878 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82151230 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 0.81516087 |
| 97 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.80699784 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80229218 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80139043 |
| 100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79653547 |
| 101 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.79606819 |
| 102 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.77643782 |
| 103 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.77576977 |
| 104 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77107066 |
| 105 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.77099356 |
| 106 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.75720630 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75078799 |
| 108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74868217 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74488765 |
| 110 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74110454 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70991212 |
| 112 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.70461298 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70117011 |
| 114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70065380 |
| 115 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.69763079 |
| 116 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.69730840 |
| 117 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.69223852 |
| 118 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.67777539 |
| 119 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.67173177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.43332348 |
| 2 | MP0005387_immune_system_phenotype | 5.02648265 |
| 3 | MP0001790_abnormal_immune_system | 5.02648265 |
| 4 | MP0001800_abnormal_humoral_immune | 4.94613054 |
| 5 | MP0000685_abnormal_immune_system | 4.03682527 |
| 6 | MP0002452_abnormal_antigen_presenting | 3.74457322 |
| 7 | MP0005671_abnormal_response_to | 3.61324168 |
| 8 | MP0003763_abnormal_thymus_physiology | 3.51234830 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.48390103 |
| 10 | MP0002723_abnormal_immune_serum | 3.29448023 |
| 11 | MP0003303_peritoneal_inflammation | 3.26002479 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 3.19177849 |
| 13 | * MP0001819_abnormal_immune_cell | 3.09024036 |
| 14 | MP0002398_abnormal_bone_marrow | 2.99394948 |
| 15 | * MP0000716_abnormal_immune_system | 2.73028420 |
| 16 | * MP0000689_abnormal_spleen_morphology | 2.54391138 |
| 17 | MP0001873_stomach_inflammation | 2.51248662 |
| 18 | MP0004510_myositis | 2.23696649 |
| 19 | * MP0002429_abnormal_blood_cell | 2.21567592 |
| 20 | MP0005025_abnormal_response_to | 2.19565926 |
| 21 | * MP0002722_abnormal_immune_system | 2.19066882 |
| 22 | MP0002405_respiratory_system_inflammati | 2.13568958 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.09045960 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.07214963 |
| 25 | MP0002419_abnormal_innate_immunity | 1.99476816 |
| 26 | MP0009785_altered_susceptibility_to | 1.99212221 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.97116567 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.87044910 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.86312349 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.86106362 |
| 31 | MP0000703_abnormal_thymus_morphology | 1.85769874 |
| 32 | MP0003436_decreased_susceptibility_to | 1.81828430 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.78399688 |
| 34 | MP0001853_heart_inflammation | 1.65912191 |
| 35 | MP0002933_joint_inflammation | 1.64679239 |
| 36 | MP0004947_skin_inflammation | 1.61932913 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.59609211 |
| 38 | MP0003866_abnormal_defecation | 1.59107181 |
| 39 | MP0004381_abnormal_hair_follicle | 1.46687412 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.46055408 |
| 41 | MP0002006_tumorigenesis | 1.41526523 |
| 42 | MP0008057_abnormal_DNA_replication | 1.40498282 |
| 43 | MP0005310_abnormal_salivary_gland | 1.38068628 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.31333599 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.27598962 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.18636929 |
| 47 | MP0002254_reproductive_system_inflammat | 1.17120279 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.15871372 |
| 49 | MP0006082_CNS_inflammation | 1.06890781 |
| 50 | MP0001851_eye_inflammation | 1.02672364 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.00844625 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 0.99087440 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 0.96878404 |
| 54 | MP0002136_abnormal_kidney_physiology | 0.95621902 |
| 55 | MP0008469_abnormal_protein_level | 0.95008915 |
| 56 | MP0002019_abnormal_tumor_incidence | 0.94128855 |
| 57 | MP0003091_abnormal_cell_migration | 0.93364808 |
| 58 | MP0009278_abnormal_bone_marrow | 0.91716965 |
| 59 | MP0008961_abnormal_basal_metabolism | 0.91566180 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 0.89618300 |
| 61 | MP0003077_abnormal_cell_cycle | 0.87656106 |
| 62 | MP0000490_abnormal_crypts_of | 0.84611893 |
| 63 | MP0003045_fibrosis | 0.82225440 |
| 64 | MP0009840_abnormal_foam_cell | 0.77689349 |
| 65 | MP0008004_abnormal_stomach_pH | 0.77576482 |
| 66 | MP0005076_abnormal_cell_differentiation | 0.74759346 |
| 67 | MP0003787_abnormal_imprinting | 0.74213475 |
| 68 | MP0004883_abnormal_blood_vessel | 0.74168507 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 0.72543923 |
| 70 | MP0000569_abnormal_digit_pigmentation | 0.71129813 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.70414669 |
| 72 | MP0001663_abnormal_digestive_system | 0.68991651 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.67707532 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.67631275 |
| 75 | MP0003724_increased_susceptibility_to | 0.67267625 |
| 76 | MP0008260_abnormal_autophagy | 0.66170728 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.64348806 |
| 78 | MP0010094_abnormal_chromosome_stability | 0.63696075 |
| 79 | MP0000858_altered_metastatic_potential | 0.62960681 |
| 80 | MP0002928_abnormal_bile_duct | 0.62958535 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.62508050 |
| 82 | MP0002653_abnormal_ependyma_morphology | 0.61760965 |
| 83 | MP0005390_skeleton_phenotype | 0.61680036 |
| 84 | MP0005381_digestive/alimentary_phenotyp | 0.61418851 |
| 85 | MP0002009_preneoplasia | 0.58740430 |
| 86 | MP0000249_abnormal_blood_vessel | 0.57677344 |
| 87 | MP0001764_abnormal_homeostasis | 0.55027927 |
| 88 | MP0003448_altered_tumor_morphology | 0.53679522 |
| 89 | MP0006054_spinal_hemorrhage | 0.53495350 |
| 90 | MP0000350_abnormal_cell_proliferation | 0.52687755 |
| 91 | MP0000767_abnormal_smooth_muscle | 0.51917432 |
| 92 | MP0008874_decreased_physiological_sensi | 0.49961873 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.49557164 |
| 94 | MP0005166_decreased_susceptibility_to | 0.49410415 |
| 95 | MP0002132_abnormal_respiratory_system | 0.48543347 |
| 96 | MP0003693_abnormal_embryo_hatching | 0.48536075 |
| 97 | MP0003795_abnormal_bone_structure | 0.48440878 |
| 98 | MP0009764_decreased_sensitivity_to | 0.48034327 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.47486963 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.47301195 |
| 101 | MP0005058_abnormal_lysosome_morphology | 0.46478482 |
| 102 | MP0000313_abnormal_cell_death | 0.46328698 |
| 103 | MP0005621_abnormal_cell_physiology | 0.45885288 |
| 104 | MP0008058_abnormal_DNA_repair | 0.45759949 |
| 105 | MP0005451_abnormal_body_composition | 0.45470142 |
| 106 | MP0001545_abnormal_hematopoietic_system | 0.45117172 |
| 107 | MP0005397_hematopoietic_system_phenotyp | 0.45117172 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.44109767 |
| 109 | MP0003828_pulmonary_edema | 0.44033201 |
| 110 | MP0002168_other_aberrant_phenotype | 0.43372118 |
| 111 | MP0008873_increased_physiological_sensi | 0.42811179 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.42506392 |
| 113 | MP0000477_abnormal_intestine_morphology | 0.42010920 |
| 114 | MP0003279_aneurysm | 0.41592727 |
| 115 | MP0003075_altered_response_to | 0.40826726 |
| 116 | MP0000343_altered_response_to | 0.40650273 |
| 117 | MP0005023_abnormal_wound_healing | 0.40484087 |
| 118 | MP0001986_abnormal_taste_sensitivity | 0.40339723 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.39997421 |
| 120 | MP0000371_diluted_coat_color | 0.39909440 |
| 121 | MP0009763_increased_sensitivity_to | 0.39743399 |
| 122 | MP0005164_abnormal_response_to | 0.38369177 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.38192178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 8.55867799 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 7.62124891 |
| 3 | Recurrent bronchitis (HP:0002837) | 7.09678155 |
| 4 | Recurrent sinusitis (HP:0011108) | 6.05748475 |
| 5 | IgM deficiency (HP:0002850) | 5.72780973 |
| 6 | Colitis (HP:0002583) | 5.48217629 |
| 7 | Cellulitis (HP:0100658) | 5.33397469 |
| 8 | Inflammation of the large intestine (HP:0002037) | 5.10287678 |
| 9 | Lymphopenia (HP:0001888) | 5.09746411 |
| 10 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.09491103 |
| 11 | Papilloma (HP:0012740) | 4.90437566 |
| 12 | Verrucae (HP:0200043) | 4.90437566 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 4.89298387 |
| 14 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.87713033 |
| 15 | Emphysema (HP:0002097) | 4.82465563 |
| 16 | Chronic sinusitis (HP:0011109) | 4.75803296 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 4.68299794 |
| 18 | Recurrent viral infections (HP:0004429) | 4.64963937 |
| 19 | Chronic otitis media (HP:0000389) | 4.59788704 |
| 20 | Meningitis (HP:0001287) | 4.49268791 |
| 21 | Vasculitis (HP:0002633) | 4.30103383 |
| 22 | IgA deficiency (HP:0002720) | 4.29799582 |
| 23 | Abnormality of macrophages (HP:0004311) | 4.23105156 |
| 24 | Bronchitis (HP:0012387) | 4.11049561 |
| 25 | Orchitis (HP:0100796) | 4.09055433 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.76442108 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.76442108 |
| 28 | T lymphocytopenia (HP:0005403) | 3.72463647 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.72435023 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.67243329 |
| 31 | Abnormality of T cell number (HP:0011839) | 3.64939109 |
| 32 | Restrictive lung disease (HP:0002091) | 3.61149813 |
| 33 | Recurrent otitis media (HP:0000403) | 3.52954445 |
| 34 | Recurrent lower respiratory tract infections (HP:0002783) | 3.51188991 |
| 35 | Abnormality of T cells (HP:0002843) | 3.50015866 |
| 36 | Recurrent pneumonia (HP:0006532) | 3.44963549 |
| 37 | Recurrent abscess formation (HP:0002722) | 3.44209831 |
| 38 | IgG deficiency (HP:0004315) | 3.42624623 |
| 39 | Osteomyelitis (HP:0002754) | 3.40725080 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 3.31795633 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 3.25651971 |
| 42 | Chronic diarrhea (HP:0002028) | 3.24688895 |
| 43 | B lymphocytopenia (HP:0010976) | 3.20234371 |
| 44 | Abnormality of B cell number (HP:0010975) | 3.20234371 |
| 45 | Abnormality of the fingertips (HP:0001211) | 3.18907628 |
| 46 | Thyroiditis (HP:0100646) | 3.15368109 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 3.14446618 |
| 48 | Nasal polyposis (HP:0100582) | 3.11717145 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 3.07925637 |
| 50 | Eczematoid dermatitis (HP:0000976) | 3.07630701 |
| 51 | Lymphoma (HP:0002665) | 3.00465407 |
| 52 | Hemoptysis (HP:0002105) | 3.00329138 |
| 53 | Small epiphyses (HP:0010585) | 2.99557560 |
| 54 | Recurrent skin infections (HP:0001581) | 2.96952049 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.95833352 |
| 56 | Increased IgM level (HP:0003496) | 2.88969253 |
| 57 | Sepsis (HP:0100806) | 2.82065533 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.75892886 |
| 59 | Thrombocytosis (HP:0001894) | 2.74104296 |
| 60 | Leukopenia (HP:0001882) | 2.71896222 |
| 61 | Encephalitis (HP:0002383) | 2.71871507 |
| 62 | Viral hepatitis (HP:0006562) | 2.69817482 |
| 63 | Urticaria (HP:0001025) | 2.68419208 |
| 64 | Leukocytosis (HP:0001974) | 2.66385325 |
| 65 | Pustule (HP:0200039) | 2.64627672 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.61971524 |
| 67 | Anorexia (HP:0002039) | 2.59784599 |
| 68 | Increased IgE level (HP:0003212) | 2.54716161 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.51475060 |
| 70 | Obstructive lung disease (HP:0006536) | 2.51014216 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51014216 |
| 72 | Abnormality of the pleura (HP:0002103) | 2.45534416 |
| 73 | Hypochromic anemia (HP:0001931) | 2.45409162 |
| 74 | Mitral stenosis (HP:0001718) | 2.44963769 |
| 75 | Spontaneous hematomas (HP:0007420) | 2.35806913 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.29765521 |
| 77 | Stomach cancer (HP:0012126) | 2.28931509 |
| 78 | Gingivitis (HP:0000230) | 2.27925881 |
| 79 | Skin ulcer (HP:0200042) | 2.27630051 |
| 80 | Combined immunodeficiency (HP:0005387) | 2.27263833 |
| 81 | Skin rash (HP:0000988) | 2.26292327 |
| 82 | Xerostomia (HP:0000217) | 2.23947424 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.23937872 |
| 84 | Pulmonary embolism (HP:0002204) | 2.22652310 |
| 85 | Stomatitis (HP:0010280) | 2.20358178 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.19244841 |
| 87 | Vertebral arch anomaly (HP:0008438) | 2.18004942 |
| 88 | Gangrene (HP:0100758) | 2.17743178 |
| 89 | Myositis (HP:0100614) | 2.16666543 |
| 90 | Arthralgia (HP:0002829) | 2.15972820 |
| 91 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.12890589 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.08399863 |
| 93 | Abnormality of the prostate (HP:0008775) | 2.07940649 |
| 94 | Increased density of long bones (HP:0006392) | 2.07866869 |
| 95 | Joint swelling (HP:0001386) | 2.07240711 |
| 96 | Severe combined immunodeficiency (HP:0004430) | 2.07181236 |
| 97 | Neutropenia (HP:0001875) | 2.06279917 |
| 98 | Basal cell carcinoma (HP:0002671) | 2.01894571 |
| 99 | Severe visual impairment (HP:0001141) | 2.01627531 |
| 100 | Epistaxis (HP:0000421) | 2.01456667 |
| 101 | Acrocyanosis (HP:0001063) | 2.01354651 |
| 102 | Hypochromic microcytic anemia (HP:0004840) | 1.99153987 |
| 103 | Petechiae (HP:0000967) | 1.96048933 |
| 104 | Premature loss of primary teeth (HP:0006323) | 1.94917140 |
| 105 | Albinism (HP:0001022) | 1.94811190 |
| 106 | Polyneuropathy (HP:0001271) | 1.94566278 |
| 107 | Abnormality of eosinophils (HP:0001879) | 1.92252421 |
| 108 | Villous atrophy (HP:0011473) | 1.92185767 |
| 109 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.92185767 |
| 110 | Episodic fever (HP:0001954) | 1.91345494 |
| 111 | Eosinophilia (HP:0001880) | 1.89618651 |
| 112 | Hematochezia (HP:0002573) | 1.89017748 |
| 113 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.88797523 |
| 114 | Hepatitis (HP:0012115) | 1.87481492 |
| 115 | Flattened epiphyses (HP:0003071) | 1.86824418 |
| 116 | Chest pain (HP:0100749) | 1.86732233 |
| 117 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84541071 |
| 118 | Fatigue (HP:0012378) | 1.82111782 |
| 119 | Bronchiectasis (HP:0002110) | 1.81585916 |
| 120 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78018477 |
| 121 | Reticulocytopenia (HP:0001896) | 1.72887198 |
| 122 | Granulocytopenia (HP:0001913) | 1.72797874 |
| 123 | Retrobulbar optic neuritis (HP:0100654) | 1.72206382 |
| 124 | Optic neuritis (HP:0100653) | 1.72206382 |
| 125 | Periodontitis (HP:0000704) | 1.72187277 |
| 126 | Pulmonary fibrosis (HP:0002206) | 1.71949259 |
| 127 | Papilledema (HP:0001085) | 1.69389021 |
| 128 | Arterial thrombosis (HP:0004420) | 1.69304281 |
| 129 | Irregular vertebral endplates (HP:0003301) | 1.68089408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.43037537 |
| 2 | GRK6 | 3.36478217 |
| 3 | BLK | 2.74629905 |
| 4 | MAP3K14 | 2.70543649 |
| 5 | STK10 | 2.60578538 |
| 6 | CSF1R | 2.58544967 |
| 7 | SYK | 2.57294636 |
| 8 | BTK | 2.39821003 |
| 9 | JAK1 | 2.24980200 |
| 10 | MAP3K10 | 2.19648332 |
| 11 | MAP3K13 | 2.17315128 |
| 12 | LRRK2 | 2.15918580 |
| 13 | PRPF4B | 2.11744693 |
| 14 | TYK2 | 2.07770654 |
| 15 | MST4 | 2.00776166 |
| 16 | IRAK3 | 1.98207002 |
| 17 | RIPK4 | 1.93621350 |
| 18 | JAK3 | 1.93505347 |
| 19 | SIK2 | 1.90606177 |
| 20 | ERN1 | 1.85218838 |
| 21 | ITK | 1.82483441 |
| 22 | CDK12 | 1.72586741 |
| 23 | IKBKB | 1.58623464 |
| 24 | TBK1 | 1.53867007 |
| 25 | KIT | 1.51461416 |
| 26 | CSK | 1.50005421 |
| 27 | TEC | 1.49476955 |
| 28 | LYN | 1.47913661 |
| 29 | MARK3 | 1.46065978 |
| 30 | HCK | 1.43285709 |
| 31 | IKBKE | 1.42781139 |
| 32 | TXK | 1.42359243 |
| 33 | ZAP70 | 1.40090802 |
| 34 | SIK3 | 1.37977259 |
| 35 | IRAK4 | 1.36297618 |
| 36 | EEF2K | 1.34964137 |
| 37 | LCK | 1.33486151 |
| 38 | PRKCQ | 1.26694976 |
| 39 | FGFR4 | 1.26426262 |
| 40 | TAOK1 | 1.24391193 |
| 41 | CLK1 | 1.24179011 |
| 42 | FES | 1.23884878 |
| 43 | MAP3K11 | 1.19660190 |
| 44 | PIM1 | 1.17124055 |
| 45 | GRK1 | 1.14072646 |
| 46 | PRKCH | 1.12798592 |
| 47 | FGFR3 | 1.11975878 |
| 48 | MUSK | 1.11802866 |
| 49 | CHUK | 1.09391775 |
| 50 | TGFBR2 | 1.06281533 |
| 51 | NLK | 0.99625848 |
| 52 | BRD4 | 0.96038338 |
| 53 | RPS6KA4 | 0.94219332 |
| 54 | ALK | 0.90384059 |
| 55 | MAP3K3 | 0.89705264 |
| 56 | TNK2 | 0.82438618 |
| 57 | PASK | 0.79182357 |
| 58 | MAP2K2 | 0.78398832 |
| 59 | HIPK2 | 0.77880696 |
| 60 | EIF2AK3 | 0.75153929 |
| 61 | PRKD2 | 0.73079286 |
| 62 | SIK1 | 0.71848177 |
| 63 | EPHB1 | 0.70556378 |
| 64 | TAOK2 | 0.66908996 |
| 65 | EPHA3 | 0.62715862 |
| 66 | IRAK2 | 0.60340775 |
| 67 | MAP3K1 | 0.59774389 |
| 68 | MELK | 0.59359137 |
| 69 | MAPK7 | 0.58541521 |
| 70 | IRAK1 | 0.56677525 |
| 71 | MAPK11 | 0.56501354 |
| 72 | MATK | 0.55879241 |
| 73 | TAOK3 | 0.52861375 |
| 74 | INSR | 0.51857622 |
| 75 | MAPK15 | 0.51465736 |
| 76 | CDC42BPA | 0.51450816 |
| 77 | CDK9 | 0.51077044 |
| 78 | TLK1 | 0.50723320 |
| 79 | MAPK12 | 0.50688628 |
| 80 | MAP3K7 | 0.49110435 |
| 81 | PDK1 | 0.48366163 |
| 82 | ABL1 | 0.48273640 |
| 83 | YES1 | 0.47617927 |
| 84 | DYRK1B | 0.46872535 |
| 85 | FGR | 0.45943168 |
| 86 | CSNK1A1L | 0.44863365 |
| 87 | CDK4 | 0.44668522 |
| 88 | FYN | 0.43438218 |
| 89 | JAK2 | 0.40474813 |
| 90 | CDK19 | 0.40350869 |
| 91 | GRK7 | 0.38640660 |
| 92 | PDPK1 | 0.38153730 |
| 93 | RPS6KL1 | 0.35299863 |
| 94 | RPS6KC1 | 0.35299863 |
| 95 | MAP2K3 | 0.34865088 |
| 96 | PTK6 | 0.34436099 |
| 97 | RPS6KA6 | 0.33942167 |
| 98 | NUAK1 | 0.33712237 |
| 99 | ADRBK2 | 0.32506051 |
| 100 | PRKCD | 0.31625691 |
| 101 | ACVR1B | 0.30234782 |
| 102 | STK24 | 0.30233903 |
| 103 | EGFR | 0.30203361 |
| 104 | CSNK1G1 | 0.28946815 |
| 105 | BMPR2 | 0.28432820 |
| 106 | ARAF | 0.28286899 |
| 107 | NEK2 | 0.27811684 |
| 108 | CSNK1G3 | 0.27444458 |
| 109 | PRKD1 | 0.27219464 |
| 110 | CDK3 | 0.27064632 |
| 111 | SGK3 | 0.26928699 |
| 112 | STK4 | 0.26688392 |
| 113 | TRIB3 | 0.26578361 |
| 114 | STK11 | 0.25891702 |
| 115 | CAMKK1 | 0.24517115 |
| 116 | MARK2 | 0.24291977 |
| 117 | MAPK4 | 0.24084824 |
| 118 | CAMKK2 | 0.23221084 |
| 119 | PRKCI | 0.22082808 |
| 120 | MAPKAPK2 | 0.21347579 |
| 121 | MAP3K8 | 0.20984078 |
| 122 | MAPK3 | 0.20856019 |
| 123 | PKN1 | 0.20091060 |
| 124 | KDR | 0.18580797 |
| 125 | CAMK1G | 0.16814803 |
| 126 | TESK2 | 0.16683321 |
| 127 | NME2 | 0.16519219 |
| 128 | RPS6KA5 | 0.16087449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.47451382 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 5.36705893 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.22635253 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.96087280 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.93579825 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.58730592 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.52651234 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36674976 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.36608327 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.08702731 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.00920830 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98803816 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.97620835 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.89426220 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.88750991 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66142791 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.54172061 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52312166 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46855669 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41884586 |
| 21 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.40214240 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.37689983 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37674856 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35636492 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34852979 |
| 26 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33125263 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.24927922 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.20393496 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20063676 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.19945296 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.18891531 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.13660614 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.13163133 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.12172742 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11451490 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.06053592 |
| 37 | Mismatch repair_Homo sapiens_hsa03430 | 1.01603190 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00074387 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 0.99159793 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.97885265 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94978192 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94397258 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92230426 |
| 44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89440790 |
| 45 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89427224 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88759745 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.88754486 |
| 48 | Malaria_Homo sapiens_hsa05144 | 0.87818727 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87802018 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87798251 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86342553 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83702347 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81258306 |
| 54 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.79713035 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79476900 |
| 56 | Spliceosome_Homo sapiens_hsa03040 | 0.78529498 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.76427997 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.75794544 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67910712 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67375336 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65761019 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65289519 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 0.65234036 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61409996 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60455682 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58946643 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57211363 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56279855 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.56083389 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.55526429 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 0.54203526 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53987014 |
| 73 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53520423 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.52364768 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50640846 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49703355 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47322337 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.46119707 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.45749321 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45108564 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44792285 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42789370 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40064856 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40004766 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39584669 |
| 86 | RNA degradation_Homo sapiens_hsa03018 | 0.38833223 |
| 87 | Prostate cancer_Homo sapiens_hsa05215 | 0.37915869 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.36900579 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.36195298 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.35784076 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34943281 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34724514 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33345598 |
| 94 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33129783 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.33035228 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32600016 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31855644 |
| 98 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.31178200 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29815717 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29781542 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.29741569 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29217691 |
| 103 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28898568 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27909252 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27536158 |
| 106 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27447844 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.26507197 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26093965 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24417683 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24179093 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23480196 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23379748 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22974024 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.21527675 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21325275 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17564437 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16825130 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15395542 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15184374 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.13989999 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13075082 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13070709 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12233186 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.12027491 |
| 125 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.10880755 |

